RNCOS

Global API Market Forecast to 2017

Press Release   •   Jul 17, 2013 15:59 IST

The market for Active Pharmaceutical Ingredients is brimming with activities. While it is consolidating in US and EU resulting in the emergence of few big players producing specialty APIs that target high value markets, new players are entering in the mass markets of India and China. With global healthcare spending to have reached around US$ 6.4 Trillion in 2010 and a rapidly ageing population boosting the demand for pharmaceuticals, APIs represent one of the most exciting markets for growth.

In our latest research study, “Global API Market Forecast to 2017”, RNCOS analysts identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 113 Billion in 2012, is expected to grow at a CAGR of around 8% during 2012-2017.

For our study, we have analyzed the global API market from different perspectives. It has been studied at the “Captive vs. Merchant” level; “Branded vs. Generic” level and “Synthetic vs. Biotech level”. This has been done to provide a thorough and apt assessment to players who can use the research findings to support their business strategies.

At the regional level, RNCOS has provided a thorough understanding of the merchant API markets along with their future outlook to 2017. Each region’s market is unique with exports playing a major role in regions of India and China. Each region’s regulatory environment has also been elaborated, while discussing various drivers and challenges, to help new entrants overcome entry barriers. The report also provides a comparative analysis of key regions highlighting labor cost and productivity; price structure with reference to manufacturing indicators of profit margins, raw materials and conversion costs; and investment incurred in plant setups. These research findings will aid international players to strategically expand their presence globally.

RNCOS, while doing the research, throughly studied the global revenue patterns of key players. The company’s report covers an overview of all the major players to provide a holistic view of the competitive landscape. Furthermore, the report elaborates on the High Potency API (HPAPI) market dynamics that represents the fastest growing niche. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global API market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM612.htm

Some of our Related Reports are:

- US Nutraceuticals Market Forecast to 2017 (http://www.rncos.com/Report/IM496.htm)
- Personalized Medicine Market Analysis (http://www.rncos.com/Report/IM305.htm)
- Asia Pacific Pharma Sector Analysis (http://www.rncos.com/Report/IM226.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.